{"id":3323,"date":"2022-01-27T08:18:17","date_gmt":"2022-01-27T08:18:17","guid":{"rendered":"https:\/\/aceoncology.org\/?p=3323"},"modified":"2022-01-27T08:18:45","modified_gmt":"2022-01-27T08:18:45","slug":"second-line-car-t-cell-therapy-large-b-cell-lymphoma","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/","title":{"rendered":"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6"},"content":{"rendered":"\n<p>\u590d\u53d1\u6027\/\u96be\u6cbb\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08LBCL\uff09\u7684\u6807\u51c6\u4e8c\u7ebf\u6cbb\u7597\u662f\u633d\u6551\u6027\u5316\u7597\uff0c\u968f\u540e\u5bf9\u7f13\u89e3\u60a3\u8005\u8fdb\u884c\u5927\u5242\u91cf\u5316\u7597\u8054\u5408\u81ea\u4f53\u5e72\u7ec6\u80de\u79fb\u690d\uff08ASCT\uff09\u3002\u7136\u800c\uff0c\u8be5\u65b9\u6cd5\u4ec5\u9650\u4e8e\u5e74\u8f7b\u3001\u9002\u5408\u7684\u60a3\u8005\uff0c\u5bf9\u5316\u7597\u96be\u6cbb\u6027\u75be\u75c5\u60a3\u8005\u76f8\u5bf9\u65e0\u6548\u3002\u9776\u5411CD19\u7684\u5d4c\u5408\u6297\u539f\u53d7\u4f53\uff08CAR\uff09-T\u7ec6\u80de\u6cbb\u7597\uff08axicabtagene ciloleucel [axi-cel]\u3001lisocabtagene maraleucel [liso-cel]\u548ctisagenlecleucel [tisa-cel]\uff09\u5728\u63a5\u53d7\u8fc72\u7ebf\u4ee5\u4e0a\u6cbb\u7597\u7684LBCL\u60a3\u8005\uff08\u5305\u62ec\u96be\u6cbb\u6027\u75be\u75c5\u60a3\u8005\uff09\u4e2d\u7684\u7f13\u89e3\u7387\u9ad8\u8fbe40%\uff0c\u5e76\u5df2\u5728\u4e09\u7ebf\u6cbb\u7597\u4e2d\u83b7\u5f97\u6279\u51c6\u3002\u5728II\u671f\u8bd5\u9a8c\u4e2d\uff0c\u6240\u6709\u4e09\u79cdCAR-T\u7ec6\u80de\u7597\u6cd5\u5747\u663e\u793a\u51fa\u76f8\u4f3c\u7684\u7597\u6548\u548c\u6bd2\u6027\u7279\u5f81\u3002\u7136\u800c\uff0c\u8fc4\u4eca\u4e3a\u6b62\uff0c\u5c1a\u65e0\u8bd5\u9a8c\u76f4\u63a5\u6bd4\u8f83\u5b83\u4eec\u3002<\/p>\n\n\n\n<p>\u4e3a\u4e86\u6539\u5584\u60a3\u8005\u7ed3\u5c40\uff0c\u5728\u4e8c\u7ebf\u6cbb\u7597\u80cc\u666f\u4e0b\u7684III\u671f\u7814\u7a76\uff08TRANSFORM\u3001ZUMA7\u548cBELINDA\uff09\u4e2d\u5bf9\u4e09\u79cdCAR-T\u7ec6\u80de\u7597\u6cd5\u8fdb\u884c\u4e86\u8bc4\u4ef7\uff0c\u5e76\u5c06\u5176\u4e0e\u6807\u51c6\u5316\u7597\u540eASCT\u8fdb\u884c\u4e86\u6bd4\u8f83\u3002\u8fd9\u4e9b\u8bd5\u9a8c\u7684\u65b0\u7ed3\u679c\u5df2\u4e8e12\u6708\u57282021\u5e74\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a\u4e0a\u516c\u5e03\u3002\u540c\u65f6\uff0c<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2116133\">ZUMA7<\/a>\u548c<a href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2116596\">BELINDA<\/a>\u7684\u7ed3\u679c\u53d1\u8868\u5728\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\u4e0a\u3002<\/p>\n\n\n\n<p>ZUMA7\u8bd5\u9a8c\u6bd4\u8f83\u4e86axi-cel\u4e0e\u6807\u51c6\u6cbb\u7597\u3002\u5728\u4e2d\u4f4d\u968f\u8bbf24.9\u4e2a\u6708\u65f6\uff0caxi-cel\u7ec4\u7684\u4e2d\u4f4d\u65e0\u4e8b\u4ef6\u751f\u5b58\u671f\uff08EFS\uff09\u663e\u8457\u957f\u4e8eASCT\u7ec4\uff088.3\u4e2a\u6708vs. 2.0\u4e2a\u6708\uff1b\u98ce\u9669\u6bd4[HR]=0.40\uff1bP &lt; 0.001\uff09\u3002axi-cel\u7684\u603b\u7f13\u89e3\u7387\uff08ORR\uff09\u4e5f\u66f4\u9ad8\uff0883% vs 50%\uff09\uff0c\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u7387\u5206\u522b\u4e3a65% vs 32%\u3002\u5728<a href=\"https:\/\/ash.confex.com\/ash\/2021\/webprogram\/Paper147913.html\">TRANSFORM<\/a>\u8bd5\u9a8c\u4e2d\uff0c\u968f\u8bbf6\u4e2a\u6708\u65f6\uff0cliso-cel\u663e\u793aEFS\u548cCR\u7387\u7684\u6539\u5584\u4e0e\u5bf9\u7167\u7ec4\u76f8\u4f3c\u3002\u76f8\u53cd\uff0c\u5728BELINDA\u8bd5\u9a8c\u4e2d\uff0c\u4e2d\u4f4d\u968f\u8bbf10\u4e2a\u6708\u65f6\uff0c\u4e0e\u6807\u51c6\u6cbb\u7597\u76f8\u6bd4\uff0ctisa-cel\u6cbb\u7597\u672a\u6539\u5584EFS\uff08\u4e24\u7ec4\u5747\u4e3a3.0\u4e2a\u6708\uff0cHR=1.07\uff0cP = 0.69\uff09\u6216CR\u7387\uff0828.4% vs 27.5%\uff09\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c3\u9879\u8bd5\u9a8c\u7684\u4e0d\u826f\u4e8b\u4ef6\u76f8\u4f3c\uff0c\u91cd\u5ea6\u4e0d\u826f\u4e8b\u4ef6\u5e76\u4e0d\u5e38\u89c1\u3002<\/p>\n\n\n\n<p>\u6211\u4eec\u53ef\u4ee5\u4ece\u8fd9\u4e9b\u4e0d\u540c\u7684\u7ed3\u679c\u4e2d\u83b7\u5f97\u4ec0\u4e48\uff1f<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe2118899\">NEJM\u7f16\u8f91\u8bc4\u8bba<\/a>\u5f3a\u8c03\uff0c\u60a3\u8005\u9009\u62e9\u6807\u51c6\u7684\u5dee\u5f02\u3001\u73b0\u5b9e\u4e16\u754c\u7684\u5316\u7597\u5dee\u5f02\uff0c\u5c24\u5176\u662f\u6865\u63a5\u5316\u7597\u7684\u4f7f\u7528\u53ef\u80fd\u662f\u5f71\u54cd\u8bd5\u9a8c\u7ed3\u679c\u7684\u91cd\u8981\u56e0\u7d20\u3002\u5728ZUMA7\u4e2d\uff0c\u60a3\u8005\u53ef\u4ee5\u4ec5\u63a5\u53d7\u7cd6\u76ae\u8d28\u6fc0\u7d20\u4f5c\u4e3a\u6865\u63a5\u6cbb\u7597\uff0c\u8fd9\u662f\u7f16\u8f91\u63cf\u8ff0\u4e3a\u201c\u76f8\u5bf9\u4e8e\u75be\u75c5\u5feb\u901f\u8fdb\u5c55\u6216\u4f53\u79ef\u8f83\u5927\u7684\u60a3\u8005\uff0c\u5b58\u5728\u76f8\u5f53\u5927\u7684\u5165\u7ec4\u504f\u501a\u201d\u7684\u5165\u7ec4\u6807\u51c6\u3002BELINDA\u7684\u8bd5\u9a8c\u8bbe\u8ba1\u786e\u5b9e\u5141\u8bb8\u6700\u591a\u4e24\u79cd\u633d\u6551\u6027\u5316\u7597\u65b9\u6848\u3002\u6b64\u5916\uff0cBELINDA\u4e2d\u8fdb\u884cASCT\u7684\u60a3\u8005\u6bd4\u4f8b\u7565\u4f4e\u4e8eZUMA7\u8fd9\u4e00\u4e8b\u5b9e\u53ef\u80fd\u8868\u660eBELINDA\u60a3\u8005\u7684\u603b\u4f53\u9884\u540e\u66f4\u5dee\u3002\u6b64\u5916\uff0c\u66f4\u77ed\u7684axi-cel\u5904\u7406\u548c\u5468\u8f6c\u65f6\u95f4\u4e5f\u53ef\u80fd\u6709\u52a9\u4e8e\u5728ZUMA-7\u8bd5\u9a8c\u4e2d\u83b7\u5f97\u6709\u5229\u7684\u4e34\u5e8a\u7ed3\u5c40\uff0c\u8bc1\u660e\u60a3\u6709\u8fd9\u4e9b\u4fb5\u88ad\u6027\u6dcb\u5df4\u7624\u7684\u60a3\u8005\u5fc5\u987b\u5c3d\u5feb\u63a5\u53d7\u6cbb\u7597\u3002<\/p>\n\n\n\n<p>\u7f16\u8f91\u8bc4\u8bba\u7684\u7cbe\u534e\u6709\u54ea\u4e9b\uff1f<\/p>\n\n\n\n<ol class=\"wp-block-list\" type=\"1\"><li>ZUMA-7\u8bd5\u9a8c\u6e05\u695a\u5730\u8868\u660e\uff0c\u4e0eASCT\u4f5c\u4e3a\u4e8c\u7ebf\u6cbb\u7597\u76f8\u6bd4\uff0c\u9002\u5408ASCT\u7684\u590d\u53d1\u6027\u6216\u96be\u6cbb\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u60a3\u8005\uff08\u5355\u72ec\u4f7f\u7528\u7cd6\u76ae\u8d28\u6fc0\u7d20\u6865\u63a5\u6cbb\u7597\u53ef\u63a7\u5236\u75c5\u60c5\uff09\u5e94\u4f18\u5148\u8003\u8651\u4f7f\u7528axicabtagene ciloleucel\u3002<\/li><li>\u81f3\u4e8eBELINDA\uff0c\u8be5\u8bc4\u8bba\u7ee7\u7eed\u6307\u51fa\uff0c\u5bf9\u4e8e\u6240\u6709\u7b26\u5408ASCT\u6761\u4ef6\u7684\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u60a3\u8005\uff0c\u63a8\u8350CAR-T\u7ec6\u80de\u7597\u6cd5\u53ef\u80fd\u4e3a\u65f6\u8fc7\u65e9\uff0c\u201c\u5c24\u5176\u662f\u90a3\u4e9b\u75be\u75c5\u4f53\u79ef\u8f83\u5927\u6216\u8fdb\u5c55\u8fc5\u901f\u7684\u60a3\u8005\uff0c\u9700\u8981\u66f4\u79ef\u6781\u7684\u6865\u63a5\u5316\u7597\u3002\u201d<\/li><li>\u7efc\u4e0a\u6240\u8ff0\uff0c\u5e76\u975e\u6240\u6709\u590d\u53d1\u6027\/\u96be\u6cbb\u6027LBCL\u60a3\u8005\u90fd\u662f\u76f8\u540c\u7684\uff0c\u56e0\u6b64\u8bc4\u4f30\u60a3\u8005\u662f\u5426\u9002\u5408CAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u5e94\u7528\u975e\u5e38\u91cd\u8981\u3002<\/li><\/ol>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e:<\/strong><br>Locke FL, et al.<em> N Engl J Med<\/em>. 2021 Dec 11. [Online ahead of print]<br>Bishop MR, et al. <a><em>N Engl J Med<\/em>. 2021 Dec 11. [Online ahead of print]<\/a><br>Roschewski M, et al. <em>N Engl J Med<\/em>. 2021 Dec 11. [Online ahead of print]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u590d\u53d1\u6027\/\u96be\u6cbb\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08LBCL\uff09\u7684\u6807\u51c6\u4e8c\u7ebf\u6cbb\u7597\u662f\u633d\u6551\u6027\u5316\u7597\uff0c\u968f\u540e\u5bf9\u7f13\u89e3\u60a3\u8005\u8fdb\u884c\u5927\u5242\u91cf\u5316\u7597\u8054\u5408\u81ea\u4f53\u5e72\u7ec6\u80de [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":3320,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[86],"tags":[],"class_list":["post-3323","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-86"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6 - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u6700\u8fd1\u7684\u4e34\u5e8a\u7814\u7a76\u6570\u636e\u663e\u793a\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u7ed3\u679c\u4e0d\u4e00\u81f4\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6 - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u6700\u8fd1\u7684\u4e34\u5e8a\u7814\u7a76\u6570\u636e\u663e\u793a\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u7ed3\u679c\u4e0d\u4e00\u81f4\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-27T08:18:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-27T08:18:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1-1024x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ACE Demo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ACE Demo\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/\"},\"author\":{\"name\":\"ACE Demo\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\"},\"headline\":\"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6\",\"datePublished\":\"2022-01-27T08:18:17+00:00\",\"dateModified\":\"2022-01-27T08:18:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/\"},\"wordCount\":112,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png\",\"articleSection\":[\"\u6587\u7ae0\u4eae\u70b9\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/\",\"name\":\"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6 - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png\",\"datePublished\":\"2022-01-27T08:18:17+00:00\",\"dateModified\":\"2022-01-27T08:18:45+00:00\",\"description\":\"\u6700\u8fd1\u7684\u4e34\u5e8a\u7814\u7a76\u6570\u636e\u663e\u793a\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u7ed3\u679c\u4e0d\u4e00\u81f4\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png\",\"width\":2667,\"height\":1500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\",\"name\":\"ACE Demo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"caption\":\"ACE Demo\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6 - ACE Oncology","description":"\u6700\u8fd1\u7684\u4e34\u5e8a\u7814\u7a76\u6570\u636e\u663e\u793a\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u7ed3\u679c\u4e0d\u4e00\u81f4","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/","og_locale":"zh_CN","og_type":"article","og_title":"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6 - ACE Oncology","og_description":"\u6700\u8fd1\u7684\u4e34\u5e8a\u7814\u7a76\u6570\u636e\u663e\u793a\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u7ed3\u679c\u4e0d\u4e00\u81f4","og_url":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/","og_site_name":"ACE Oncology","article_published_time":"2022-01-27T08:18:17+00:00","article_modified_time":"2022-01-27T08:18:45+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1-1024x576.png","type":"image\/png"}],"author":"ACE Demo","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"ACE Demo","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/"},"author":{"name":"ACE Demo","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0"},"headline":"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6","datePublished":"2022-01-27T08:18:17+00:00","dateModified":"2022-01-27T08:18:45+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/"},"wordCount":112,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png","articleSection":["\u6587\u7ae0\u4eae\u70b9"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/","url":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/","name":"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6 - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png","datePublished":"2022-01-27T08:18:17+00:00","dateModified":"2022-01-27T08:18:45+00:00","description":"\u6700\u8fd1\u7684\u4e34\u5e8a\u7814\u7a76\u6570\u636e\u663e\u793a\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u7684\u7ed3\u679c\u4e0d\u4e00\u81f4","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-74-1.png","width":2667,"height":1500},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/second-line-car-t-cell-therapy-large-b-cell-lymphoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\u4e8c\u7ebfCAR-T\u7ec6\u80de\u6cbb\u7597\u6570\u636e\u89e3\u5bc6"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0","name":"ACE Demo","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","caption":"ACE Demo"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=3323"}],"version-history":[{"count":2,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3323\/revisions"}],"predecessor-version":[{"id":3325,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3323\/revisions\/3325"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/3320"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=3323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=3323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=3323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}